Position in IONS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$77,080,557
-$3,604,198 QoQ
Shares Held
1,026,509
+0.6% QoQ
Ownership
0.621%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 70.09056910363182.ToString("F0")%
Shared 0.ToString("F0")%
None 29.90943089636818.ToString("F0")%
Common Shares in IONS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,440,401,210 across 521 Biotechnology names. IONS ranks #38 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in IONS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $77,080,557 | 1,026,509 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $80,684,755 | 1,019,906 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $77,216,268 | 1,180,316 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $53,820,872 | 1,362,209 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $34,519,937 | 1,144,181 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $46,494,311 | 1,329,929 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $52,496,662 | 1,310,451 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $48,270,278 | 1,012,805 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $50,441,967 | 1,163,598 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $55,156,398 | 1,090,263 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $46,875,201 | 1,033,404 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $46,318,270 | 1,128,888 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $35,847,537 | 1,003,009 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $35,379,494 | 936,709 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $30,807,871 | 696,538 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $27,319,903 | 737,977 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $19,241,425 | 519,477 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $14,146,448 | 464,885 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $16,700,771 | 497,936 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $21,046,320 | 527,609 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $25,522,306 | 567,667 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $23,924,051 | 423,135 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $9,114,573 | 192,088 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $13,471,530 | 228,486 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $9,585,922 | 202,748 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||